Cargando…
MON-317 Ectopic Cushing's Syndrome Due to Prostate Cancer: A Case Series
Background: The introduction of chemotherapy and androgen receptor signaling inhibitors to patients with newly diagnosed metastatic or castration resistant prostate cancer has resulted in longevity and improved quality of life. However, as the disease transitions to a more resistant clinical state d...
Autores principales: | Kanbour, Sarah, Braunstein, Rebecca, Sinha, Avani, Slovin, Susan, Geer, Eliza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550628/ http://dx.doi.org/10.1210/js.2019-MON-317 |
Ejemplares similares
-
SUN-927 Ectopic Cushing Syndrome Due to a Metastatic Neuroendocrine Tumor to the Breast
por: Zhang, Jian, et al.
Publicado: (2020) -
MON-905 A Case of Cushing’s Disease with Glucocorticoid Positive-Feedback
por: Shichi, Hiroki, et al.
Publicado: (2020) -
Atypical Carcinoid Tumor of the Mediastinum Presenting as Ectopic Cushing’s Syndrome
por: Medina Mora, Luis Augusto, et al.
Publicado: (2021) -
MON-902 Etomidate - an Under Utilized but Safe and Efficacious Drug to Treat Acute Severe Cushing’s Syndrome- Case Reports of Ectopic ACTH Syndrome from Neuroendocrine Malignancies
por: Cherian, Elena Thampy, et al.
Publicado: (2020) -
THU531 A Case Of Cushing Syndrome Due To Ectopic ACTH Secreting Lung Neuroendocrine Tumor Treated With Cryoablation
por: Paknikar, Sujaytha, et al.
Publicado: (2023)